L

Lepu Medical Technology Beijing Co Ltd
SZSE:300003

Watchlist Manager
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Watchlist
Price: 11.91 CNY 0.25% Market Closed
Market Cap: 22.4B CNY
Have any thoughts about
Lepu Medical Technology Beijing Co Ltd?
Write Note

Gross Margin
Lepu Medical Technology Beijing Co Ltd

61%
Current
61%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
61%
=
Gross Profit
4B
/
Revenue
6.5B

Gross Margin Across Competitors

Country CN
Market Cap 22.4B CNY
Gross Margin
61%
Country US
Market Cap 199B USD
Gross Margin
56%
Country US
Market Cap 191.3B USD
Gross Margin
67%
Country US
Market Cap 141.3B USD
Gross Margin
64%
Country US
Market Cap 134.2B USD
Gross Margin
69%
Country IE
Market Cap 104.6B USD
Gross Margin
65%
Country US
Market Cap 65.6B USD
Gross Margin
45%
Country DE
Market Cap 58.1B EUR
Gross Margin
38%
Country US
Market Cap 44.5B USD
Gross Margin
79%
Country CN
Market Cap 311.1B CNY
Gross Margin
64%
Country US
Market Cap 36.3B USD
Gross Margin
41%
No Stocks Found

Lepu Medical Technology Beijing Co Ltd
Glance View

Market Cap
22.4B CNY
Industry
Health Care

Lepu Medical Technology Beijing Co Ltd. was born in the vibrant landscape of China's rapidly evolving healthcare industry. Established in 1999, the company has grown into a formidable player in the medical device sector. It carved its niche by focusing on cardiovascular interventions, technological innovations, and pharmaceuticals. At its core, Lepu Medical thrives on leveraging its research and development expertise to create products that cater to a broad spectrum of medical needs, particularly in the cardiovascular domain. They manufacture and distribute a wide range of medical devices which include coronary stents, pacemakers, and other related products, enabling them to secure a strong foothold in both domestic and international markets. Revenue generation for Lepu Medical is a multifaceted process that leverages the company's comprehensive vertical integration strategy. The company has strategically developed a robust portfolio not only in medical devices but also in pharmaceuticals and healthcare services. This diversified offering allows them to capture value across the entire patient care continuum—from device manufacturing and pharmaceuticals to post-operative care and services. By continually investing in innovation and expanding their reach through strategic partnerships and acquisitions, Lepu Medical ensures a consistent revenue stream, reinforcing its position within the global healthcare landscape. The company's commitment to quality and technological advancement keeps it competitive, propelling its growth across various health sectors.

Intrinsic Value
19.45 CNY
Undervaluation 39%
Intrinsic Value
Price
L

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
61%
=
Gross Profit
4B
/
Revenue
6.5B
What is the Gross Margin of Lepu Medical Technology Beijing Co Ltd?

Based on Lepu Medical Technology Beijing Co Ltd's most recent financial statements, the company has Gross Margin of 61%.